Related Experiment Video
Updated: Jul 19, 2026

Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
Published on: September 11, 2012
Azoxymethane protects intestinal stem cells and reduces crypt epithelial mitosis through a COX-1-dependent mechanism
Terrence E Riehl1, Robert J George, Mark A Sturmoski
1Division of Gastroenterology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract:
Azoxymethane (AOM) is a potent DNA-damaging agent and carcinogen that induces intestinal and colonic tumors in rodents. Evaluation of the stem cell population by colony formation assay reveals that, within 8 h after treatment, AOM (10 mg/kg) elicited a prosurvival response. In wild-type (WT) mice, AOM treatment induced a 2.5-fold increase in intestinal crypt stem cell survival. AOM treatment increased stem cell survival in cyclooxygenase (COX)-2(-/-) but not COX-1(-/-) mice, confirming a role of COX-1 in the AOM-induced increase in stem cell survival. COX-1 mRNA and protein expression as well as COX-1-derived PGE(2) synthesis were increased 8 h after AOM treatment. Immunohistochemical staining of COX-1 demonstrated expression of the enzyme in the crypt epithelial cells, especially in the columnar epithelial cells between the Paneth cells adjacent to the stem cell zone. WT mice receiving AOM exhibited increased intestinal apoptosis and a simultaneous reduction in crypt mitotic figures within 8 h of injection. There were no significant differences in baseline or AOM-induced intestinal epithelial apoptosis between WT and COX-1(-/-) mice, but there was a complete reversal of the AOM-mediated reduction in mitosis in COX-1(-/-) mice. This suggests that COX-1-derived PGE(2) may play a key role in the early phase of intestinal tumorigenesis in response to DNA damage and suggests that COX-1 may be a potential therapeutic target in this model of colon cancer.
Insights
Azoxymethane (AOM) DNA damage triggers a prosurvival response in intestinal stem cells, mediated by cyclooxygenase-1 (COX-1). This suggests COX-1 is crucial for early colon cancer development and a potential therapeutic target.
Area of Science:
- Gastroenterology
- Molecular Biology
- Cancer Research
Background:
- Azoxymethane (AOM) is a carcinogen that induces DNA damage, leading to intestinal and colonic tumors in rodents.
- AOM treatment elicits a prosurvival response in intestinal stem cells within hours.
- Cyclooxygenase (COX) enzymes are implicated in inflammation and cancer development.
Purpose of the Study:
- To investigate the role of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) in the early prosurvival response of intestinal stem cells to Azoxymethane (AOM).
- To determine the involvement of COX-1-derived prostaglandin E2 (PGE2) in mediating AOM-induced effects on intestinal stem cell survival, apoptosis, and mitosis.
Main Methods:
- Utilized wild-type (WT), COX-1 knockout (COX-1(-/-)), and COX-2 knockout (COX-2(-/-)) mice.
- Administered AOM (10 mg/kg) and evaluated intestinal crypt stem cell survival using colony formation assays.
- Assessed COX-1 mRNA and protein expression, PGE2 synthesis, intestinal apoptosis, and crypt mitotic figures via immunohistochemistry and other methods.
Main Results:
- AOM treatment significantly increased intestinal crypt stem cell survival in WT mice.
- Stem cell survival increased in COX-2(-/-) mice but not in COX-1(-/-) mice, indicating a critical role for COX-1.
- COX-1 expression and PGE2 synthesis were upregulated post-AOM, with COX-1 localized to crypt epithelial cells. AOM-induced reduction in mitosis was reversed in COX-1(-/-) mice, while apoptosis levels remained similar.
Conclusions:
- Cyclooxygenase-1 (COX-1)-derived prostaglandin E2 (PGE2) plays a significant role in the early phase of intestinal tumorigenesis following DNA damage induced by Azoxymethane (AOM).
- COX-1 mediates the prosurvival response and affects mitotic activity in intestinal stem cells after AOM exposure.
- COX-1 represents a potential therapeutic target for colon cancer in models involving DNA damage.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Renewal of Intestinal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs that Stabilize Microtubules
Adult Stem Cells